There is also evidence of a shift of TRPV1 function from anti-inflammatory to pro-inflammatory in systemic inflammatory response syndrome (SIRS) and sepsis models as an organism ages, shedding light on another factor to consider when utilizing TRPV1-targeted therapy in older patients. This evidence concerns the gene TRPV1 and systemic inflammatory response syndrome.